Stock Yards Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Stock Yards Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$313K	Buy	701 +10	+1%	+$4.66K	0.01%	331
2025 Q4	$313K	Sell	691 -98	-12%	-$42.2K	0.01%	333
2025 Q3	$309K	Sell	789 -20	-2%	-$8.36K	0.01%	332
2025 Q2	$360K	Buy	809 +295	+57%	+$136K	0.01%	310
2025 Q1	$249K	Buy	514 +9	+2%	+$4.19K	0.01%	348
2024 Q4	$203K	Buy	+505	New	+$234K	0.01%	359
2023 Q3	–	Sell	-799	Closed	-$281K	–	404
2023 Q2	$281K	Sell	799 -87	-10%	-$29.3K	0.01%	338
2023 Q1	$279K	Hold	886	–	–	0.01%	348
2022 Q4	$256K	Buy	886 +5	+0.6%	+$1.52K	0.01%	368
2022 Q3	$255K	Hold	881	–	–	0.01%	360
2022 Q2	$248K	Buy	+881	New	+$236K	0.01%	376

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Stock Yards Bank & Trust's VRTX Position: Q1 2026 in Review

Stock Yards Bank & Trust increased its Vertex Pharmaceuticals (VRTX) stake by 1.4% in Q1 2026, buying an estimated $4.66K and bringing the position to 701 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #331.

Stock Yards Bank & Trust first reported a position in VRTX in Q2 2022 and has held it in 11 quarters since. The position peaked at $360K in Q2 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Stock Yards Bank & Trust held 701 shares of Vertex Pharmaceuticals worth $313K as of Q1 2026.
Stock Yards Bank & Trust bought 10 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.66K.
Vertex Pharmaceuticals made up 0.01% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #331 holding.
Stock Yards Bank & Trust first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
Stock Yards Bank & Trust's Vertex Pharmaceuticals position peaked at $360K in Q2 2025.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.